Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR‐30a inhibits androgen‐independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4

15 Apr 2020

Abstract excerpt

BACKGROUND: Castrate-resistant prostate cancer (CRPC) is an aggressive and lethal disease. The pathogenesis of CRPC is not fully understood and novel therapeutic targets need to be identified to improve the patients' prognosis. MicroRNA-30a (miR-30a) has been demonstrated to be a tumor suppressor in many types of solid malignancies. However, its role in androgen-independent (AI) growth of prostate cancer (PCa)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to MicroRNA in disease regulation
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32294305
DOI: 10.1002/pros.23979

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR‐30a inhibits androgen‐independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4PMID 32294305Read ↗

Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screeningSemantic proximity Read ↗

The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.Semantic proximity Read ↗

Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancerSemantic proximity Read ↗

Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancerSemantic proximity Read ↗

Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer CellsSemantic proximity Read ↗

The lncRNA <i>DRAIC</i> / <i>PCAT29</i> Locus Constitutes a Tumor-Suppressive NexusSemantic proximity Read ↗

lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axisSemantic proximity Read ↗

Lentiviral vector‐mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcomeSemantic proximity Read ↗

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration‐resistant prostate cancerSemantic proximity Read ↗

CUL4B/miR‐33b/C‐MYC axis promotes prostate cancer progressionSemantic proximity Read ↗

Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysisSemantic proximity Read ↗

E2F7, regulated by miR‑30c, inhibits apoptosis and promotes cell cycle of prostate cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.